| [1] | Li PY, Lai PS, Hung WC, et al. Poly(l-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells[J].Biomacromolecules 2010,11(10):2576-2582. |
| [2] | Kibria G, Hatakeyama H, Harashima H.Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system[J].Arch Pharm Res, 2014, 37(1): 4-15. |
| [3] | Thierry AR, Vige D, Coughlin SS, et al. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes[J].FASEB J, 1993,7(6):572-579. |
| [4] | Kumar SA, Peter YA, Nadeau JL. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin[J].Nanotechnology,2008,10(49):495101. |
| [5] | Barraud L, Merle P, Soma E, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo[J].J Hepatol 2005,42(5):736-743. |
| [6] | Ma P, Mumper RJ. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review[J].Nano Today,2013,8(3):313-331. |
| [7] | Wang X, Cai X, Hu J, et al. Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles[J].J Am Chem Soc 2013,135(26):9805-9810. |
| [8] | Gu YJ, Cheng J, Man CW, et al. Gold-doxorubicin nanoconjugates for overcoming multidrug resistance[J]. Nanomedicine, 2012,8(2):204-211. |